Investigating brain health in breast cancer survivors undergoing hormone therapy
Official title: Brain Health in Breast Cancer Survivors: Interaction of Menopause and Endocrine Therapy
Run by Jonsson Comprehensive Cancer Center · NCT04297020 · Data updated 2026-11-12
This study is trying to see how hormone therapy affects brain function in breast cancer survivors, especially looking at how menopause plays a role.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 35 Years to 65 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Jonsson Comprehensive Cancer Center Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | March 11, 2020 |
| Main results expected | March 15, 2027 |
| Study ends | March 15, 2028 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT04297020 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include women aged 35-65 who are fluent in English and have adequate vision and hearing to complete testing.
✕Probably not a fit
Patients with a history of major neurocognitive disorders, major neurological conditions, or prior cancer treatments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the effects of endocrine therapy on cognitive function in breast cancer survivors, particularly focusing on the role of menopausal status. By employing a cross-sectional, 2x2 factorial design, the study will compare brain activity between survivors on endocrine therapy and healthy controls using advanced fMRI techniques during a working memory task. The research seeks to address inconsistencies in previous studies by considering menopausal status and utilizing sensitive cognitive measures. The findings could provide insights into how hormone therapy impacts brain health in this population.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of cognitive health in breast cancer survivors undergoing hormone therapy.
How similar studies have gone: While some studies have explored cognitive effects of hormone therapy, this approach using sensitive fMRI measures in the context of menopausal status is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 35-65 * Fluent in English * Adequate vision/hearing to complete testing Exclusion Criteria: * History of major or mild neurocognitive disorder or dementia * Diagnosis of major neurological condition (e.g., epilepsy, Parkinson's Disease, stroke) * Diagnosis of a major psychiatric disorder (e.g., bipolar disorder, schizophrenia) * Untreated/unstable unipolar depression or anxiety * Prior history of cancer or chemotherapy (for controls, any history) * History of a learning disorder * History of head injury with loss of consciousness \>20 minutes * History of salpingo-oophorectomy or hysterectomy * A cardiac pacemaker * Implanted electronic device * Claustrophobia * Currently pregnant * Orbital metal implant or other metallic foreign bodies Additional exclusion criteria for controls: current use of a contraceptive agent that interferes with endogenous hormonal fluctuation (e.g., oral contraceptive pill) or precludes determination of menstrual pattern (e.g., hormonally secreting intrauterine device), or current treatment with systemic estrogen replacement therapy.
Where it's running
-
University of California at Los Angeles
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Kathleen Van Dyk, PhD — University of California at Los Angeles
- Study coordinator: Kathleen Van Dyk, PhD
- Email: KVanDyk@mednet.ucla.edu
- Phone: 310 825-2719
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
-
Omega-3 Fatty Acids and Red Blood Cell Membranes in Competitive Soccer Players
This study tests whether high-dose omega-3 supplements change red blood cell membranes and may affect performance and cognition in competitive male soccer players aged 16–35.
-
Immediate vs progressive standing dual-task training for older adults with mild to moderate cognitive impairment
This study tests whether starting with immediate standing dual-task training is better or worse than progressively increasing the difficulty for older adults with mild to moderate cognitive impairment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.